Built for intratumoral immunotherapy translation.
A lean founding team with deep gene-therapy and IO expertise, supported by an advisory board of intratumoral immunotherapy leaders from BIOTHERIS, MSKCC, Columbia, Dartmouth and Precision for Medicine.
Ariel Yusupov, MS
Inventor of the Symphony™ platform. Years at Pfizer & J&J leading RNA, cell and gene therapy programs.
Sanjukta Chakraborty, PhD
10+ years cancer immunology. Formerly Weill Cornell & Arvinas.
Deep clinical, translational and IP experience.
Click any photo to view a full biography.
Aurélien Marabelle, MD, PhD
Director, BIOTHERIS Center for Intratumoral Immunotherapies. Globally recognized IO leader.
Mark Stein, MD
Prostate-cancer immunotherapy expert; led multiple clinical trials.
Matthew Dallos, MD
Leading a direct-injection prostate immunotherapy trial at Memorial Sloan Kettering.
Steven Fiering, PhD
Decade-plus in intratumoral solid-tumor IO and DNA cytokine delivery.
Jenny Zilberberg, PhD
VP Scientific Strategy; former Head of Research at Imvax.
Maya Elbert, PhD
IO gene/cell-therapy and antibody patent strategy.